Question 1

What are the potential risks and side effects of the huCART19-IL18-eDHFR treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma clinical trial (NCT07343934). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma clinical trial (NCT07343934). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the imaging with [18F]Fluoropropyl-Trimethoprim involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma clinical trial (NCT07343934). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any other treatment options available to me besides this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma clinical trial (NCT07343934). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in the study, and what will my visits look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma clinical trial (NCT07343934). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma clinical trial (NCT07343934). Contact the study team or your healthcare provider for specific answers.

What this study is about